Long-term treatment of patient with metastatic melanoma of the trunk

被引：0

作者：

Kempa-Kaminska, Natasza ^{[1
]}

机构：

[1] Dolnoslaskie Ctr Onkol Wroclawiu, Oddzial Onkol Klin, Pl Hirszfelda 12, PL-53413 Wroclaw, Poland

来源：

ONCOLOGY IN CLINICAL PRACTICE | 2018年 / 14卷

关键词：

immunotherapy; melanoma; vemurafenib; hepatotoxicity;

D O I：

10.5603/OCP.2018.0063

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Currently there has been a huge development in melanoma therapy. There are drugs with high efficacy, but also with a completely new toxicity profile. Below is a case report of a patient treated for metastatic melanoma of the body. Treatment included vemurafenib and immunotherapy in the form of pembrolizumab, a monoclonal antibody blocking PD-1 receptor. Among toxicity, dermatological effects of vemurafenib treatment and hepatotoxicity during immunotherapy were observed mainly in case of treatment with vemurafenib. The applied treatment allowed for several years of survival of the patient in good general condition.

引用

页码：A19 / A22

页数：4

共 50 条

[11] Survival and long-term toxicities of biochemotherapy for metastatic melanoma
Minor, D. R.
Miller, J.
Kashani-Sabet, M.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[12] Long-term Survival after Metastatic Childhood Melanoma
Larsen, Anne Kristine
Jensen, Mette Bybjerg
Krag, Christen
PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN, 2014, 2 (06)
[13] Long-term survival in metastatic uveal melanoma (MUM)
Neumann, Sophie Piperno
Dureau, Sylvain
Rodrigues, Manuel Jorge
Desjardins, Laurence
Pierron, Gaelle
Levy-Gabriel, Christine
Lumbroso, Livia
Servois, Vincent
Najean, Marie
Savignoni, Alexia
Cassoux, Nathalie
Mariani, Pascale
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[14] Long-term Survival in Metastatic Malignant Melanoma: Ipilimumab Followed by Vemurafenib in a Patient with Brain Metastasis
Balakan, Ozan
Suner, Ali
Yigiter, Remzi
Balakan, Tuba
Sirikci, Akif
Sevinc, Alper
INTERNAL MEDICINE, 2012, 51 (19) : 2819 - 2823
[15] Long-term control of leptomeningeal disease after radiation therapy and nivolumab in a metastatic melanoma patient
Wu, Richard C.
Newman, William
Patanowitz, Liron
Branstetter, Barton F.
Amankulor, Nduka
Tarhini, Ahmad A.
IMMUNOTHERAPY, 2020, 12 (11) : 763 - 769
[16] Long-term survival for patients with detectable metastatic melanoma at time of treatment with patient-specific tumor stem cell vaccines
Dillman, Robert Owen
DePriest, Carol
Ellis, Robin Anne
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[17] Long-Term Outcomes of Immune Checkpoint Inhibition in Metastatic Melanoma
Francesca Aroldi
Mark R. Middleton
American Journal of Clinical Dermatology, 2022, 23 : 331 - 338
[18] Clinical determinants of long-term survival in metastatic uveal melanoma
Elias A. T. Koch
Anne Petzold
Anja Wessely
Edgar Dippel
Michael Erdmann
Lucie Heinzerling
Bettina Hohberger
Harald Knorr
Ulrike Leiter
Friedegund Meier
Peter Mohr
Farnaz Rahimi
Beatrice Schell
Max Schlaak
Patrick Terheyden
Beatrice Schuler-Thurner
Selma Ugurel
Jochen Utikal
Julio Vera
Michael Weichenthal
Fabian Ziller
Carola Berking
Markus V. Heppt
Cancer Immunology, Immunotherapy, 2022, 71 : 1467 - 1477
[19] Swinging for the Fences: Long-Term Survival With Ipilimumab in Metastatic Melanoma
Gibney, Geoffrey T.
Atkins, Michael B.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (17) : 1873 - U27
[20] Clinical determinants of long-term survival in metastatic uveal melanoma
Koch, Elias A. T.
Petzold, Anne
Wessely, Anja
Dippel, Edgar
Erdmann, Michael
Heinzerling, Lucie
Hohberger, Bettina
Knorr, Harald
Leiter, Ulrike
Meier, Friedegund
Mohr, Peter
Rahimi, Farnaz
Schell, Beatrice
Schlaak, Max
Terheyden, Patrick
Schuler-Thurner, Beatrice
Ugurel, Selma
Utikal, Jochen
Vera, Julio
Weichenthal, Michael
Ziller, Fabian
Berking, Carola
Heppt, Markus, V
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (06) : 1467 - 1477

← 1 2 3 4 5 →